Trial intelligence / Profile preview

Parecoxib in Hospitalized Patients With Spontaneous Subarachnoid Hemorrhage

NCT06579274Phase 2Recruiting

Sponsor
St. Anne's University Hospital Brno
Start
Jan 2025
Primary completion
Jan 2027
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of parecoxib in subarachnoid hemorrhage (SAH), sponsored by St. Anne's University Hospital Brno. Started Jan 2025; status: recruiting.

02

Drugs

parecoxib
03

Conditions

subarachnoid hemorrhage (SAH)

Beyond the preview

Go deeper on NCT06579274.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06579274.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call